Utama › Kanser Metastatik › Tennessee › Chattanooga
Kajian klinikal Kanser Metastatik di Chattanooga, TN
6 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi dalam dan sekitar Chattanooga (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Mengambil pesertaFasa 3
- Research Site, Chattanooga
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Tennessee Oncology, PLLC - Chattanooga Downtown, Chattanooga
- Tennessee Oncology, PLLC - Chattanooga - Medical Park II, Chattanooga
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Mengambil pesertaFasa 1/2
- Tennessee Oncology, PLLC- Chattanooga Downtown, Chattanooga
- Tennessee Oncology, PLLC - Chattanooga Med Park II, Chattanooga
- Tennessee Oncology, PLLC - Chattanooga Memorial, Chattanooga
- dan 2 lagi
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Tennessee Oncology Chattanooga, Chattanooga
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Tennessee Oncology, PLLC, Chattanooga
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Mengambil pesertaFasa 1/2
- Tennessee Oncology, Chattanooga
Kajian Kanser Metastatik di bandar lain
- Houston, TX104 kajian
- New York City, NY93 kajian
- Nashville, TN70 kajian
- Boston, MA63 kajian
- Los Angeles, CA57 kajian
- St. Louis, MO54 kajian
- Arlington, VA53 kajian
- Philadelphia, PA46 kajian
- Chicago, IL45 kajian
- San Antonio, TX44 kajian
- Washington, DC43 kajian
- Dallas, TX42 kajian
Kajian lain di Chattanooga
- Kanser Paru-paru Bukan Sel Kecil11 kajian
- Myasthenia Gravis6 kajian
- Kanser Ovari5 kajian
- Diabetes4 kajian
- Penyakit Hati Steatotik4 kajian
- Melanoma4 kajian
- Stroke Iskemia4 kajian
- Kanser Kolorektal4 kajian
- Penyakit Buah Pinggang Kronik4 kajian
- Kanser Paru-paru4 kajian
- Kegagalan Ginjal3 kajian
- Aterosklerosis3 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.